Thursday, May 23, 2013 10:32:06 PM
I think so. I've been following NNVC pretty closely for many months. I have never seen the trading act as positively as in this week.
Volume is way up. Very good sign. No breakout yet, but lots of great accumulation with an upwards bias in price.
I don't believe in coincidence. I know some of the new interest started with internet stock posting services. I would not call it pumping, but definitely presented NNVC is a positive light. As far as I could tell, the information provided was accurate and not overly hyped.
The financial releases yesterday; I thought, were very positive. I was surprised the stock did not advance more upon the release. NNVC has plenty of cash on hand, and the company is making progress on its stated objectives.
Where I can be most helpful to others, is in my observation of the daily trading. As I stated before, in the many months I've watched NNVC, I have never seen a more positive week in terms of trading. Volume is up. There was no dump after the good news hit. There seems to be a steady stream of new buying coming into the stock.
I have come to expect almost anything from micro-cap stocks. Things may deteriorate tomorrow. But, as best I can tell, I think things will continue to be positive for NNVC stock in the coming days. I surely did not see any weakness today. And, since there has been no exagerrated parabolic move, I think the current trend is sustainable. It just looks like some new accumulation is taking place.
Volume is way up. Very good sign. No breakout yet, but lots of great accumulation with an upwards bias in price.
I don't believe in coincidence. I know some of the new interest started with internet stock posting services. I would not call it pumping, but definitely presented NNVC is a positive light. As far as I could tell, the information provided was accurate and not overly hyped.
The financial releases yesterday; I thought, were very positive. I was surprised the stock did not advance more upon the release. NNVC has plenty of cash on hand, and the company is making progress on its stated objectives.
Where I can be most helpful to others, is in my observation of the daily trading. As I stated before, in the many months I've watched NNVC, I have never seen a more positive week in terms of trading. Volume is up. There was no dump after the good news hit. There seems to be a steady stream of new buying coming into the stock.
I have come to expect almost anything from micro-cap stocks. Things may deteriorate tomorrow. But, as best I can tell, I think things will continue to be positive for NNVC stock in the coming days. I surely did not see any weakness today. And, since there has been no exagerrated parabolic move, I think the current trend is sustainable. It just looks like some new accumulation is taking place.
Recent NNVC News
- In the Ebola Emergency, NV-387 is Ready to be Shipped to DRC, and It Compares Favorably as a Treatment for Ebola Versus Possible Options, Says NanoViricides • ACCESS Newswire • 05/26/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 10:01:46 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:30:33 PM
- NanoViricides Announces Closing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/19/2026 03:55:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/18/2026 12:45:22 PM
- Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides • ACCESS Newswire • 05/18/2026 12:30:00 PM
- NanoViricides Announces Pricing of ~$2 Million Registered Direct Offering • ACCESS Newswire • 05/15/2026 12:35:00 PM
- NanoViricides, Inc. Has Filed its Quarterly Report - NV-387 Advancing for Phase II • ACCESS Newswire • 05/15/2026 12:00:00 PM
- Recent Hantavirus On A Cruise Ship Highlights the Need for Broad-Spectrum Antiviral Drugs Such as NV-387, Says NanoViricides • ACCESS Newswire • 05/11/2026 12:30:00 PM
- NanoViricides, Inc. Announces Participation in the D. Boral Capital Global Conference • Newsfile • 05/06/2026 07:37:00 PM
- NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA • ACCESS Newswire • 05/04/2026 12:30:00 PM
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
